Stockreport

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update [Yahoo! Finance]

Grace Therapeutics, Inc.  (GRCE) 
PDF of New Drug Application (NDA) for GTx-104 FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment o [Read more]